|
Home : Environmental Toxins : Mesothelioma : Newsfeeds : Alfacell Signs Onconase Purchase And Supply Deal With Scientific ... Alfacell Signs Onconase Purchase And Supply Deal With Scientific ...
RTT News - Onconase, the company's lead drug candidate, is currently being evaluated as a treatment for unresectable malignant mesothelioma or UMM in a confirmatory Phase IIIb clinical trial. Kuslima Shogen, chief executive officer of Alfacell, said, “We have ...
Find a Mesothelioma Lawyer Now
This form is secure and encrypted. More information about secure forms and your privacy here.
|




